296 related articles for article (PubMed ID: 27593566)
1. Tumor-derived immuno-modulators induce overlapping pro-tolerogenic gene expression signatures in human dendritic cells.
Trojandt S; Bellinghausen I; Reske-Kunz AB; Bros M
Hum Immunol; 2016 Dec; 77(12):1223-1231. PubMed ID: 27593566
[TBL] [Abstract][Full Text] [Related]
2. Dendritic Cells Differentiated from Human Umbilical Cord Blood-Derived Monocytes Exhibit Tolerogenic Characteristics.
Kim SK; Yun CH; Han SH
Stem Cells Dev; 2015 Dec; 24(23):2796-807. PubMed ID: 26203805
[TBL] [Abstract][Full Text] [Related]
3. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
[TBL] [Abstract][Full Text] [Related]
4. Generation of tolerogenic dendritic cells using Lactobacillus rhamnosus and Lactobacillus delbrueckii as tolerogenic probiotics.
Esmaeili SA; Mahmoudi M; Rezaieyazdi Z; Sahebari M; Tabasi N; Sahebkar A; Rastin M
J Cell Biochem; 2018 Sep; 119(9):7865-7872. PubMed ID: 29943843
[TBL] [Abstract][Full Text] [Related]
5. Modulatory effect of rapamycin and tacrolimus on monocyte-derived dendritic cells phenotype and function.
Dahlqvist G; Renaud S; Barjon C; Lefebvre A; Aoudjehane L; Horsmans Y; Delhem N; Conti F
Immunobiology; 2021 Jan; 226(1):152031. PubMed ID: 33278711
[TBL] [Abstract][Full Text] [Related]
6. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
Bodey B; Bodey B; Kaiser HE
In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
[TBL] [Abstract][Full Text] [Related]
7. Tolerogenic dendritic cells generated with different immunosuppressive cytokines induce antigen-specific anergy and regulatory properties in memory CD4+ T cells.
Torres-Aguilar H; Aguilar-Ruiz SR; González-Pérez G; Munguía R; Bajaña S; Meraz-Ríos MA; Sánchez-Torres C
J Immunol; 2010 Feb; 184(4):1765-75. PubMed ID: 20083662
[TBL] [Abstract][Full Text] [Related]
8. Effects of monomethylfumarate on dendritic cell differentiation.
Litjens NH; Rademaker M; Ravensbergen B; Thio HB; van Dissel JT; Nibbering PH
Br J Dermatol; 2006 Feb; 154(2):211-7. PubMed ID: 16433787
[TBL] [Abstract][Full Text] [Related]
9. DC-SIGN ligation greatly affects dendritic cell differentiation from monocytes compromising their normal function.
Svajger U; Obermajer N; Anderluh M; Kos J; Jeras M
J Leukoc Biol; 2011 Jun; 89(6):893-905. PubMed ID: 21447648
[TBL] [Abstract][Full Text] [Related]
10. Niflumic acid renders dendritic cells tolerogenic and up-regulates inhibitory molecules ILT3 and ILT4.
Svajger U; Vidmar A; Jeras M
Int Immunopharmacol; 2008 Jul; 8(7):997-1005. PubMed ID: 18486911
[TBL] [Abstract][Full Text] [Related]
11. GILZ expression in human dendritic cells redirects their maturation and prevents antigen-specific T lymphocyte response.
Cohen N; Mouly E; Hamdi H; Maillot MC; Pallardy M; Godot V; Capel F; Balian A; Naveau S; Galanaud P; Lemoine FM; Emilie D
Blood; 2006 Mar; 107(5):2037-44. PubMed ID: 16293609
[TBL] [Abstract][Full Text] [Related]
12.
Ilic N; Gruden-Movsesijan A; Cvetkovic J; Tomic S; Vucevic DB; Aranzamendi C; Colic M; Pinelli E; Sofronic-Milosavljevic L
Front Immunol; 2018; 9():11. PubMed ID: 29416536
[No Abstract] [Full Text] [Related]
13. Delivery of alloantigens via apoptotic cells generates dendritic cells with an immature tolerogenic phenotype.
Gleisner MA; Rosemblatt M; Fierro JA; Bono MR
Transplant Proc; 2011; 43(6):2325-33. PubMed ID: 21839264
[TBL] [Abstract][Full Text] [Related]
14. The suppression effect of dendritic cells maturation by adipose-derived stem cells through TGF-β1 related pathway.
Wang YC; Chen RF; Brandacher G; Lee WPA; Kuo YR
Exp Cell Res; 2018 Sep; 370(2):708-717. PubMed ID: 30053444
[TBL] [Abstract][Full Text] [Related]
15. Differentially Tolerized Mouse Antigen Presenting Cells Share a Common miRNA Signature Including Enhanced mmu-miR-223-3p Expression Which Is Sufficient to Imprint a Protolerogenic State.
Bros M; Youns M; Kollek V; Buchmüller D; Bollmann F; Seo EJ; Schupp J; Montermann E; Usanova S; Kleinert H; Efferth T; Reske-Kunz AB
Front Pharmacol; 2018; 9():915. PubMed ID: 30174602
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E2 Antagonizes TGF-β Actions During the Differentiation of Monocytes Into Dendritic Cells.
Remes Lenicov F; Paletta AL; Gonzalez Prinz M; Varese A; Pavillet CE; Lopez Malizia Á; Sabatté J; Geffner JR; Ceballos A
Front Immunol; 2018; 9():1441. PubMed ID: 29988364
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cells from bench to bedside and back.
Adema GJ
Immunol Lett; 2009 Feb; 122(2):128-30. PubMed ID: 19121337
[TBL] [Abstract][Full Text] [Related]
18. Anti CD25 treatment of human dendritic cells modulates both their cytokine synthesis profiles and their capacity to activate allogeneic CD4 T cells: a potential tolerogenic effect.
Mnasria K; Lagaraine C; Manaa J; Lebranchu Y; Oueslati R
Int Immunopharmacol; 2008 Mar; 8(3):414-22. PubMed ID: 18279795
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E2 is a key factor for monocyte-derived dendritic cell maturation: enhanced T cell stimulatory capacity despite IDO.
Krause P; Singer E; Darley PI; Klebensberger J; Groettrup M; Legler DF
J Leukoc Biol; 2007 Nov; 82(5):1106-14. PubMed ID: 17698915
[TBL] [Abstract][Full Text] [Related]
20. The ratio between dendritic cells and T cells determines whether prostaglandin E2 has a stimulatory or inhibitory effect.
Shimabukuro-Vornhagen A; Liebig TM; Koslowsky T; Theurich S; von Bergwelt-Baildon MS
Cell Immunol; 2013 Jan; 281(1):62-7. PubMed ID: 23454682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
